









Markets
/
Stocks
/
nasdaq-gehc
/

GE Healthcare Technologies Inc

GEHC

74.950USD

-0.050-0.07%

Close 10/31, 16:00（ET）Quotes delayed by 15 min

34.14BMarket Cap

15.40P/E TTM



GE Healthcare Technologies Inc

74.950

-0.050-0.07%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of GE Healthcare Technologies Inc

Currency: USD Updated: 2025-10-31

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

GE Healthcare Technologies Inc's Score

Industry at a Glance

Industry Ranking

38 / 210

Overall Ranking

124 / 4618

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 22 analysts

Buy

Current Rating

88.335

Target Price

+17.78%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

GE Healthcare Technologies Inc Highlights

StrengthsRisks

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Undervalued

The company’s latest PE is 15.45, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 400.48M shares, increasing 1.80% quarter-over-quarter.

Held by HOTCHKIS & WILEY

Star Investor HOTCHKIS & WILEY holds 7.20M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.10.

Financial Health

Currency: USD Updated: 2025-10-31

The company's current financial score is 8.22, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.14B, representing a year-over-year increase of 5.76%, while its net profit experienced a year-over-year increase of 5.11%.

Score

Industry at a Glance

Previous score

8.22

Change



Financials

6.09

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.09

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.91

Key Metrics

Free cash flow

No Data

GE Healthcare Technologies Inc's Company Valuation

Currency: USD Updated: 2025-10-31

The company’s current valuation score is 6.12, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 15.45, which is 99.65% below the recent high of 30.84 and 20.50% above the recent low of 12.28.

Score

Industry at a Glance

Previous score

6.12

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 38/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-31

The company’s current earnings forecast score is 8.10, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for GE Healthcare Technologies Inc is 87.00, with a high of 108.00 and a low of 73.00.

Score

Industry at a Glance

Previous score

8.10

Change

Support & Resistance

No Data

Analyst Rating

Based on 22 analysts

Buy

Current Rating

88.335

Target Price

+17.86%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

GE Healthcare Technologies Inc

GEHC

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-31

The company’s current price momentum score is 7.21, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 79.79 and the support level at 70.07, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.22

Change

-0.01

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.120

Buy

RSI(14)

47.745

Neutral

STOCH(KDJ)(9,3,3)

36.733

Sell

ATR(14)

2.004

Low Volatility

CCI(14)

-41.957

Neutral

Williams %R

54.732

Neutral

TRIX(12,20)

0.147

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

77.016

Sell

MA10

76.820

Sell

MA20

75.215

Sell

MA50

75.123

Sell

MA100

74.518

Buy

MA200

76.155

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-31

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 87.71%, representing a quarter-over-quarter increase of 8.35%. The largest institutional shareholder is The Vanguard, holding a total of 51.90M shares, representing 11.39% of shares outstanding, with 0.53% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

51.90M

+1.36%

BlackRock Institutional Trust Company, N.A.

24.63M

-2.50%

Dodge & Cox

Star Investors

23.57M

+42.10%

Capital Research Global Investors

19.97M

-9.05%

State Street Investment Management (US)

19.66M

+1.93%

Geode Capital Management, L.L.C.

11.94M

+1.97%

Harris Associates L.P.

Star Investors

9.67M

+71.68%

Invesco Capital Management (QQQ Trust)

9.37M

-0.35%

Citadel Advisors LLC

9.30M

+34.46%

Hotchkis and Wiley Capital Management, LLC

Star Investors

7.20M

+25.17%

Risk Assessment

Currency: USD Updated: 2025-10-31

The company’s current risk assessment score is 8.32, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.